NCT06869239 2025-03-11
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
Peking University Cancer Hospital & Institute
Recruiting
Clinical Trials
3 trialsNCT04679506 2020-12-22
the Efficacy and Safety of CLAE in R/R T-ALL/LBL
Peking University Third Hospital
Unknown
NCT03130582 2017-04-28
High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Completed